FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Massimo Cugno

Research Profile

Disorders

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Roberto Castelli; Antonino Cannavò; Ramona Cassin; Massimo Cugno
Immunomodulatory drugs: new options for the treatment of myelodysplastic syndromes.
Roberto Castelli; Andrea Zanichelli; Massimo Cugno
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Angelo V Marzano; I Polloni; Alberto Tedeschi; C Crosti; Massimo Cugno
Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Massimo Cugno (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roberto Castelli; Antonino Cannavò; Ramona Cassin; Massimo Cugno
Immunomodulatory drugs: new options for the treatment of myelodysplastic syndromes.
Clinical lymphoma, myeloma & leukemia 2013;13(1):1-7.
2013: Roberto Castelli; Andrea Zanichelli; Massimo Cugno
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Immunopharmacology and immunotoxicology 2013;35(1):181-90.
2013: Angelo V Marzano; I Polloni; Alberto Tedeschi; C Crosti; Massimo Cugno
Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease.
Clinical and experimental immunology 2013;171(1):76-81.
2012: Francesca Crovetto; Massimo Cugno; Barbara Acaia; Gianluigi Ardissino; Nicolò Borsa; Pierangela Castorina; Kathy Frees; Carla Nishimura; Roberta Palla; Flora Peyvandi; Richard J H Smith; Edgardo Somigliana; Silvana Tedeschi; Luigi Fedele
The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2012;25(11):2322-5.
2012: Massimo Cugno; Riccardo Lazzari; Riccardo Asero; Alberto Tedeschi; Angelo V Marzano
Inflammation and coagulation in urticaria and angioedema.
Current vascular pharmacology 2012;10(5):653-8.
2012: Alberto Maino; Angelo V Marzano; Raffaella Rossio; Massimo Cugno; Alberto Tedeschi
Hypereosinophilic syndrome, Churg-Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis.
Current vascular pharmacology 2012;10(5):670-5.
2012: Angelo V Marzano; Ilaria Polloni; Alberto Tedeschi; Carlo Crosti; Massimo Cugno
Interactions between inflammation and coagulation in autoimmune and immune-mediated skin diseases.
Current vascular pharmacology 2012;10(5):647-52.
2012: Massimo Cugno
Inflammation, coagulation, vascular permeability and thrombosis.
Current vascular pharmacology 2012;10(5):631.
2012: Alberto Tedeschi; Riccardo Asero; Massimo Cugno
Basophil activation test and autologous serum skin test: not overlapping tests in chronic urticaria.
The Journal of allergy and clinical immunology 2012;130(1):280-1; author reply 281.
2012: Massimo Cugno; Massimo Boscolo-Anzoletti; Roberto Castelli; Daniela Mari; Enrico Mozzi; Giancarlo Roviaro; Marco Antonio Zappa; Pier Mannuccio Mannucci
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding.
Internal and emergency medicine 2012;7(3):237-42.
2011: Sonia Caccia; Roberto Castelli; Luigi Bergamaschini; Diana Maiocchi; Massimo Cugno
Interaction of C1 inhibitor with thrombin on the endothelial surface.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2011;22(7):571-5.
2011: Riccardo Asero; Alberto Tedeschi; Massimo Cugno
Markers of autoreactivity, coagulation and angiogenesis in patients with nonallergic asthma.
Allergy 2011;66(10):1339-44.
2011: Riccardo Asero; Massimo Cugno; Alberto Tedeschi
Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test.
Journal of the European Academy of Dermatology and Venereology : JEADV 2011;25(2):201-5.
2011: Massimo Cugno
Cardiovascular events and survival in rheumatoid arthritis: effects of anti-tumor necrosis factor-alpha treatment.
Translational research : the journal of laboratory and clinical medicine 2011;157(1):6-9.
2010: Alberto Tedeschi; Riccardo Asero; Maurizio Lorini; Angelo V Marzano; Massimo Cugno
Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2010;40(6):875-81.
2010: G Iapichino; M Umbrello; Maura Albicini; P Spanu; G Bellani; F Polli; R Pavlovic; Massimo Cugno; I Fermo; R Paroni
Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
Minerva anestesiologica 2010;76(5):325-33.
2010: Tommaso Mauri; Giacomo Bellani; Nicolo' Patroniti; andrea coppadoro; Giuseppe Peri; Ivan Cuccovillo; Massimo Cugno; Gaetano Iapichino; Luciano Gattinoni; antonio pesenti; Alberto Mantovani
Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
Intensive care medicine 2010;36(4):621-9.
2010: Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.
Internal and emergency medicine 2010;5(2):97-101.
2010: Francesca Ingegnoli; Flavio Fantini; S Griffini; Amedeo Soldi; Pier Luigi Meroni; Massimo Cugno
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis.
Clinical and experimental rheumatology 2010;28(2):254-7.
2010: Massimo Cugno; Alberto Tedeschi; Riccardo Asero; Pier Luigi Meroni; Angelo V Marzano
Skin autoimmunity and blood coagulation.
Autoimmunity 2010;43(2):189-94.
2010: Massimo Cugno; Maria Orietta Borghi; Laura Maria Lonati; Lorenzo Ghiadoni; Maria Gerosa; Claudia Grossi; Valentina De Angelis; Gaia Magnaghi; Angela Tincani; Daniela Mari; Piersandro Riboldi; Pier Luigi Meroni
Patients with antiphospholipid syndrome display endothelial perturbation.
Journal of autoimmunity 2010;34(2):105-10.
2010: Massimo Cugno; Francesca Ingegnoli; Roberta Gualtierotti; Flavio Fantini
Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis.
Current vascular pharmacology 2010;8(2):285-92.
2010: Massimo Cugno; Roberto Castelli; Giuliana Bisiani; Samantha Griffini; Pier Luigi Meroni
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA.
European journal of internal medicine 2010;21(1):25-9.
2010: Riccardo Asero; Alberto Tedeschi; Massimo Cugno
Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.
International archives of allergy and immunology 2010;152(4):384-9.
2009: Alberto Tedeschi; Riccardo Asero; Angelo V Marzano; Maurizio Lorini; D Fanoni; E Berti; Massimo Cugno
Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria.
Allergy 2009;64(11):1616-22.
2009: Angelo V Marzano; Alberto Tedeschi; D Spinelli; Daniele Fanoni; Carlo Crosti; Massimo Cugno
Coagulation activation in autoimmune bullous diseases.
Clinical and experimental immunology 2009;158(1):31-6.
2009: Riccardo Asero; Massimo Cugno; Alberto Tedeschi
Eosinophils in chronic urticaria: supporting or leading actors?
The World Allergy Organization journal 2009;2(9):213-7.
2009: Massimo Cugno; Alberto Tedeschi; Carlo Crosti; Angelo V Marzano
Activation of blood coagulation in autoimmune skin disorders.
Expert review of clinical immunology 2009;5(5):605-13.
2009: F Polli; M Savioli; Massimo Cugno; Paolo Taccone; Giacomo Bellani; P Spanu; antonio pesenti; Gaetano Iapichino; Luciano Gattinoni
Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic control.
Minerva anestesiologica 2009;75(7-8):417-26.
2009: Riccardo Asero; Alberto Tedeschi; Massimo Cugno
Is the autologous plasma skin test in patients with chronic urticaria really useless?
The Journal of allergy and clinical immunology 2009;123(6):1417; author reply 1417-8.
2009: Massimo Cugno; Andrea Zanichelli; Fabrizio Foieni; Sonia Caccia; Marco Cicardi
C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
Trends in molecular medicine 2009;15(2):69-78.
2009: Monica Savioli; Massimo Cugno; Federico Polli; Paolo Taccone; Giacomo Bellani; Paolo Spanu; antonio pesenti; Gaetano Iapichino; Luciano Gattinoni
Tight glycemic control may favor fibrinolysis in patients with sepsis.
Critical care medicine 2009;37(2):424-31.
2009: Massimo Cugno; Andrea Zanichelli; A G Bellatorre; S Griffini; Marco Cicardi
Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
Allergy 2009;64(2):254-7.
2009: Massimo Cugno; Angelo V Marzano; Alberto Tedeschi; Daniele Fanoni; Luigia Venegoni; Riccardo Asero
Expression of tissue factor by eosinophils in patients with chronic urticaria.
International archives of allergy and immunology 2009;148(2):170-4.
2008: Massimo Cugno; Roberto Castelli; Marco Cicardi
Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Autoimmunity reviews 2008;8(2):156-9.
2008: Massimo cazzaniga; Francesco Salerno; Stefania Visentin; Ilaria Cirello; Cesare Donarini; Massimo Cugno
Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistive index.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(10):1396-401.
2008: Gaetano Iapichino; Maura Albicini; Michele Umbrello; Francesca Sacconi; Isabella Fermo; Radmila Pavlovich; Rita Paroni; Giacomo Bellani; Giovanni Mistraletti; Massimo Cugno; antonio pesenti; Luciano Gattinoni
Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients.
Intensive care medicine 2008;34(10):1843-50.
2008: Francesca Ingegnoli; Flavio Fantini; Ennio Giulio Favalli; Amedeo Soldi; Samantha Griffini; Valentina Galbiati; Pier Luigi Meroni; Massimo Cugno
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
Journal of autoimmunity 2008;31(2):175-9.
2008: Riccardo Asero; Alberto Tedeschi; Piersandro Riboldi; S Griffini; E Bonanni; Massimo Cugno
Severe chronic urticaria is associated with elevated plasma levels of D-dimer.
Allergy 2008;63(2):176-80.
2008: Riccardo Asero; Alberto Tedeschi; Piersandro Riboldi; Samantha Griffini; Erika Bonanni; Massimo Cugno
Coagulation cascade and fibrinolysis in patients with multiple-drug allergy syndrome.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2008;100(1):44-8.
2007: Simone Saibeni; Luisa Spina; Tiziana Virgilio; Anna Folcioni; Greta Borsi; Roberto de Franchis; Massimo Cugno; Maurizio Vecchi
Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
European journal of gastroenterology & hepatology 2007;19(11):976-81.
2007: Riccardo Asero; Piersandro Riboldi; Alberto Tedeschi; Massimo Cugno; Pierluigi Meroni
Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation.
Autoimmunity reviews 2007;7(1):71-6.
2007: Riccardo Asero; Massimo Cugno; Alberto Tedeschi
Chronic urticaria: one step forward and two steps back.
Journal of the American Academy of Dermatology 2007;57(2):368-9.
2007: Riccardo Asero; Alberto Tedeschi; Raffaella Coppola; Samantha Griffini; Paolo Paparella; Piersandro Riboldi; Angelo V Marzano; Daniele Fanoni; Massimo Cugno
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.
The Journal of allergy and clinical immunology 2007;119(3):705-10.
2006: Simone Saibeni; C Ciscato; Maurizio Vecchi; M Boscolo Anzoletti; E Kaczmarek; Sonia Caccia; R de Franchis; Massimo Cugno
Antibodies to tissue-type plasminogen activator (t-PA) in patients with inflammatory bowel disease: high prevalence, interactions with functional domains of t-PA and possible implications in thrombosis.
Journal of thrombosis and haemostasis : JTH 2006;4(7):1510-6.
2006: Riccardo Asero; Alberto Tedeschi; Piersandro Riboldi; Massimo Cugno
Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum.
The Journal of allergy and clinical immunology 2006;117(5):1113-7.
2005: Qing Ling Duan; Borzoo Nikpoor; Marie-Pierre Dube; Giuseppe Molinaro; Inge A Meijer; Patrick Dion; Daniel Rochefort; Judith Saint-Onge; Leah Flury; Nancy Brown; James V Gainer; Jean-Lucien Rouleau; Angelo Agostoni; Massimo Cugno; Pierre Simon; Pierre Clavel; Jacky Potier; Bassem Wehbe; Seddik Benarbia; Julien Marc-Aurele; Jacques Chanard; Tatiana Foroud; Albert Adam; Guy Rouleau
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.
American journal of human genetics 2005;77(4):617-26.
2005: Massimo Devani; Maurizio Vecchi; Stefano Ferrero; E Contessini Avesani; C Arizzi; Lee Chao; Robert W Colman; Massimo Cugno
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2005;37(9):665-73.
2005: Massimo Cugno; Piergiuseppe Agostoni; Daniela Mari; Pier Luigi Meroni; Luisa Gregorini; Maurizio Bussotti; Gian Battista Anguissola; Francesco Donatelli; Jürg Nussberger
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
British journal of haematology 2005;130(1):113-20.
2004: Massimo Cugno; Daniela Mari; Pier Luigi Meroni; Edoardo Gronda; Francesco Vicari; Maria Frigerio; Raffaella Coppola; Bianca Bottasso; Maria Orietta Borghi; Luisa Gregorini
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
British journal of haematology 2004;126(1):85-92.
2004: Piera Angelica Merlini; Massimo Cugno; Marco L Rossi; Pietro Maria G Agricola; Alessandra Repetto; Raffaela Fetiveau; Paolo Diotallevi; Umberto Canosi; Pier Mannuccio Mannucci; Diego Ardissino
Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction.
The American journal of cardiology 2004;93(7):822-5.
2004: Massimo Cugno; Mara Cabibbe; Monica Galli; Pier Luigi Meroni; Sonia Caccia; Rosaria Russo; Bianca Bottasso; Pier Mannuccio Mannucci
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients.
Blood 2004;103(6):2121-6.
2003: Massimo Cugno; Jürg Nussberger; Marco Cicardi; Angelo Agostoni
Bradykinin and the pathophysiology of angioedema.
International immunopharmacology 2003;3(3):311-7.
2003: Federico Lussana; Maddalena L Zighetti; Paolo Bucciarelli; Massimo Cugno; Marco Cattaneo
Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users.
Thrombosis research 2003;112(1-2):37-41.
2002: Luisa Gregorini; Jean Marco; Bruno Farah; Monique Bernies; Carlo Palombo; Michaela Kozàkovà; Irene M Bossi; Bernard Cassagneau; Jean Fajadet; Carlo Di Mario; Remo Albiero; Massimo Cugno; Adalberto Grossi; Gerd Heusch
Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting.
Circulation 2002;106(23):2901-7.
2002: Daniela Mari; Federica Di Berardino; Massimo Cugno
Chronic heart failure and the immune system.
Clinical reviews in allergy & immunology 2002;23(3):325-40.
2002: Giuseppe Molinaro; Massimo Cugno; Mélissa Perez; Yves Lepage; Nicole Gervais; Angelo Agostoni; Albert Adam
Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.
The Journal of pharmacology and experimental therapeutics 2002;303(1):232-7.
2002: Jürg Nussberger; Massimo Cugno; Marco Cicardi
Bradykinin-mediated angioedema.
The New England journal of medicine 2002;347(8):621-2.
2002: Massimo Devani; Massimo Cugno; Maurizio Vecchi; Stefano Ferrero; Federica Di Berardino; E Contessini Avesani; Roberto de Franchis; Robert W Colman
Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
The American journal of gastroenterology 2002;97(8):2026-32.
2002: Albert Adam; Massimo Cugno; Giuseppe Molinaro; Melissa Perez; Yves Lepage; Angelo Agostoni
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors.
Lancet 2002;359(9323):2088-9.
2001: Angelo Agostoni; Massimo Cugno
[The kinin system: biological mechanisms and clinical implications].
Recenti progressi in medicina 2001;92(12):764-73.
2001: Massimo Cugno; Jürg Nussberger; P Biglioli; F Alamanni; R Coppola; Angelo Agostoni
Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion.
Chest 2001;120(6):1776-82.
2001: Massimo Cugno; Francesco Salerno; Jürg Nussberger; Bianca Bottasso; Elettra Lorenzano; Angelo Agostoni
Bradykinin in the ascitic fluid of patients with liver cirrhosis.
Clinical science (London, England : 1979) 2001;101(6):651-7.
2001: M Cyr; Yves Lepage; Charles Blais; Nicole Gervais; Massimo Cugno; Jean-Lucien Rouleau; Albert Adam
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.
American journal of physiology. Heart and circulatory physiology 2001;281(1):H275-83.
2001: Massimo Cugno; I Bos; Y Lubbers; C E Hack; Angelo Agostoni
In vitro interaction of C1-inhibitor with thrombin.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(4):253-60.
2001: Marco Gardinali; M R Pozzi; M Bernareggi; N Montani; E Allevi; laura catena; Massimo Cugno; Bianca Bottasso; R Stabilini
Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
The Journal of rheumatology 2001;28(4):786-94.
2001: Angelo Agostoni; Massimo Cugno; A Agostini
Influence of contact system deficiencies during cardiopulmonary bypass.
Thrombosis and haemostasis 2001;85(2):191-2.
2000: Massimo Cugno; Piergiuseppe Agostoni; H R Brunner; Marco Gardinali; Angelo Agostoni; Jürg Nussberger
Plasma bradykinin levels in human chronic congestive heart failure.
Clinical science (London, England : 1979) 2000;99(5):461-6.
2000: Massimo Cugno; M Dominguez; Mara Cabibbe; G Bisiani; M Galli; E Angles-Cano; Angelo Agostoni
Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome.
British journal of haematology 2000;108(4):871-5.
1999: Jürg Nussberger; Massimo Cugno; Marco Cicardi; Angelo Agostoni
Local bradykinin generation in hereditary angioedema.
The Journal of allergy and clinical immunology 1999;104(6):1321-2.
1999: Massimo Cugno; CF Scott; Francesco Salerno; Elettra Lorenzano; W Müller-Esterl; Angelo Agostoni; Robert W Colman
Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
Thrombosis and haemostasis 1999;82(5):1428-32.
1999: Angelo Agostoni; Marco Cicardi; Massimo Cugno; Lorenza C Zingale; D Gioffré; Jürg Nussberger
Angioedema due to angiotensin-converting enzyme inhibitors.
Immunopharmacology 1999;44(1-2):21-5.
1999: Massimo Cugno; Jürg Nussberger; P Biglioli; M G Giovagnoni; Marco Gardinali; Angelo Agostoni
Cardiopulmonary bypass increases plasma bradykinin concentrations.
Immunopharmacology 1999;43(2-3):145-7.
1999: Luigi Bergamaschini; S Canziani; Bianca Bottasso; Massimo Cugno; Paola Braidotti; Angelo Agostoni
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
Clinical and experimental immunology 1999;115(3):526-33.
1998: Marco Cicardi; Luigi Bergamaschini; Massimo Cugno; A Beretta; Lorenza C Zingale; Massimo Colombo; Angelo Agostoni
Pathogenetic and clinical aspects of C1 inhibitor deficiency.
Immunobiology 1998;199(2):366-76.
1998: Jürg Nussberger; Massimo Cugno; C Amstutz; Marco Cicardi; A Pellacani; Angelo Agostoni
Plasma bradykinin in angio-oedema.
Lancet 1998;351(9117):1693-7.
1998: Luigi Bergamaschini; L Parnetti; D Pareyson; S Canziani; Massimo Cugno; Angelo Agostoni
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease.
Alzheimer disease and associated disorders 1998;12(2):102-8.
1998: Massimo Cugno; G Bisiani; Mara Cabibbe; I Martinelli
Absence of antibodies to tissue-type plasminogen activator in patients with previous deep vein thrombosis.
International journal of clinical & laboratory research 1998;28(1):72-3.
1997: Massimo Cugno; Marco Cicardi; Bianca Bottasso; Raffaella Coppola; R Paonessa; Pier M Mannucci; Angelo Agostoni
Activation of the coagulation cascade in C1-inhibitor deficiencies.
Blood 1997;89(9):3213-8.
1996: Marco Cicardi; A Beretta; Massimo Colombo; D Gioffré; Massimo Cugno; Angelo Agostoni
Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema.
Clinical and experimental immunology 1996;106(3):475-80.
1996: Massimo Cugno; Marco Cicardi; M Colucci; G Bisiani; Piera Angelica Merlini; A Spinola; R Paonessa; Angelo Agostoni
Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
Thrombosis and haemostasis 1996;76(2):234-8.
1996: Massimo Cugno; Marco Cicardi; Raffaella Coppola; Angelo Agostoni
Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies.
Immunopharmacology 1996;33(1-3):361-4.
1995: Marco Cicardi; Massimo Cugno; A Agostoni
Cardioprotective effect of C1-inhibitor.
Circulation 1995;92(9):2758-9.
1995: Pier Alberto Testoni; Marco Cicardi; Luigi Bergamaschini; S Guzzoni; Massimo Cugno; M Buizza; Francesco Bagnolo; Angelo Agostoni
Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy.
Gastrointestinal endoscopy 1995;42(4):301-5.
1995: Massimo Cugno; Francesco Salerno; M Mandelli; Elettra Lorenzano; R Paonessa; Angelo Agostoni
Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis.
Thrombosis research 1995;78(4):277-82.
1995: Bianca Marasini; C Pipia; G DeValle; Andrea Crosignani; L Petroni; Massimo Cugno; S Zeni; Savino Bruno; C Bassani
Vascular impairment in patients with primary biliary cirrhosis.
International journal of microcirculation, clinical and experimental / sponsored by the European Society for Microcirculation 1995;15(2):75-9.
1994: Angelo Agostoni; Marco Gardinali; D Frangi; C Cafaro; L Conciato; C Sponzilli; A Salvioni; Massimo Cugno; Marco Cicardi
Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
Circulation 1994;90(6):2666-70.
1994: Angelo Agostoni; Marco Gardinali; D Frangi; Massimo Cugno; C Cafaro; L Conciato; C Sponzilli; E Salmoirago
Thrombolytic treatment and complement activation.
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1994;9(3):178-9.
1994: Marco Cicardi; Pier Alberto Testoni; Luigi Bergamaschini; S Guzzoni; Massimo Cugno; M Buizza; Francesco Bagnolo
Antiproteasic activity of C1 inhibitor. Therapeutic perspectives.
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1994;9(3):180-2.
1994: Massimo Cugno; Marco Cicardi; Angelo Agostoni
Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid.
The Journal of allergy and clinical immunology 1994;93(5):870-6.
1993: Angelo Agostoni; Marco Cicardi; Massimo Cugno; E Storti
Clinical problems in the C1-inhibitor deficient patient.
Behring Institute Mitteilungen 1993;(93):306-12.
1993: Marco Cicardi; G Bisiani; Massimo Cugno; P Späth; Angelo Agostoni
Autoimmune C1 inhibitor deficiency: report of eight patients.
The American journal of medicine 1993;95(2):169-75.
1993: Massimo Cugno; C Erik Hack; J P de Boer; A J Eerenberg; Angelo Agostoni; Marco Cicardi
Generation of plasmin during acute attacks of hereditary angioedema.
The Journal of laboratory and clinical medicine 1993;121(1):38-43.
1992: Bianca Marasini; Massimo Cugno; C Bassani; I Fabrizi; Bianca Bottasso; Angelo Agostoni
DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects.
Thrombosis and haemostasis 1992;68(5):621.
1992: Bianca Marasini; Massimo Cugno; C Bassani; M Stanzani; Bianca Bottasso; Angelo Agostoni
Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon.
International journal of microcirculation, clinical and experimental / sponsored by the European Society for Microcirculation 1992;11(4):375-82.
1991: R Marcolin; Massimo Cugno; antonio pesenti; L Uziel; A Giuffrida; G Vitale; R Keim; F Meda; I Fabrizi; Luciano Gattinoni
Extracorporeal circulation in sheep with normal bleeding time using a surface heparinized circuit.
ASAIO transactions / American Society for Artificial Internal Organs 1991;37(4):584-7.
1991: Marco Cicardi; Luigi Bergamaschini; Massimo Cugno; E Hack; G Agostoni; Angelo Agostoni
Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience.
The Journal of allergy and clinical immunology 1991;87(4):768-73.
1991: Bianca Marasini; Massimo Cugno; A Agostoni
Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon.
Arthritis and rheumatism 1991;34(2):255-6.
1991: Angelo Agostoni; Bianca Marasini; M L Biondi; C Bassani; Anna Cazzaniga; Bianca Bottasso; Massimo Cugno
L-arginine therapy in Raynaud's phenomenon?
International journal of clinical & laboratory research 1991;21(2):202-3.
1990: Massimo Cugno; L Uziel; Francesco Marongiu; Bianca Bottasso; C Legnani; G Palareti
t-PA activity elicited by venous occlusion or DDAVP infusion does not produce plasmin activity in normal subjects.
Thrombosis research 1990;59(6):1007-11.
1990: L Uziel; Massimo Cugno; I Fabrizi; antonio pesenti; Luciano Gattinoni; Angelo Agostoni
Physiopathology and management of coagulation during long-term extracorporeal respiratory assistance.
The International journal of artificial organs 1990;13(5):280-7.
1990: Massimo Cugno; J Nuijens; E Hack; A Eerenberg; D Frangi; Angelo Agostoni; Marco Cicardi
Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
The Journal of clinical investigation 1990;85(4):1215-20.
1990: P Marino; Massimo Cugno; A Preatoni; P Cori; A Rosti; L Frontini; Marco Cicardi
Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
British journal of cancer 1990;61(3):434-5.
1990: Pier M Mannucci; Massimo Cugno; Bianca Bottasso; Francesco Marongiu; M Maniezzo; M Vaglini; N Cascinelli
Changes in fibrinolysis in patients with localized tumors.
European journal of cancer (Oxford, England : 1990) 1990;26(2):83-7.
1989: Massimo Cugno; L Uziel; I Fabrizi; Bianca Bottasso; F Maggiolini; Angelo Agostoni
Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion.
Thrombosis research 1989;56(5):625-34.
1989: P M Mannucci; Massimo Cugno; Giuseppa Elisa Mameli; Francesco Marongiu; A Bianchi Bonomi
Fibrin(ogen) peptides in early breast cancer.
Thrombosis and haemostasis 1989;62(2):819.
1988: Massimo Cugno; Luigi Bergamaschini; L Uziel; Marco Cicardi; Angelo Agostoni; A F Jie; C Kluft
Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency).
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1988;26(7):423-7.
1988: G Bisiani; I Fabrizi; Massimo Cugno; Enrico Opocher; Roberto Santambrogio; L Uziel
[Prophylaxis using heparin in coagulopathies caused by peritoneo-jugular derivation].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1988;3(1):26-31.
1986: Angelo Agostoni; L Uziel; Massimo Cugno; E Cacciabue
[Blood coagulation problems during long-term extracorporeal circulation].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1986;1(3):212-20.
1986: L Uziel; Massimo Cugno; A Colombo; Angelo Agostoni; F Rossi; Luciano Gattinoni
Disseminated intravascular coagulation (DIC) during long-term bypass: incidence and clinical relevance.
ASAIO transactions / American Society for Artificial Internal Organs 1986;32(1):542-5.
1986: L Uziel; Massimo Cugno; E Cacciabue; A Colombo; R Stabilini; D Mascheroni; Angelo Agostoni
Evaluation of tests for heparin control during long-term extracorporeal circulation.
The International journal of artificial organs 1986;9(2):111-6.
1986: Massimo Cugno; A Colombo; E Cacciabue; L Uziel; Angelo Agostoni
Statistical evaluation of commonly used tests for heparin monitoring.
Life support systems : the journal of the European Society for Artificial Organs 1986;4 Suppl 1():120-8.